Investigation of interactions at the extracellular loops of the relaxin family peptide receptor 1 (RXFP1)

Journal of Biological Chemistry

Volumn 289, Issue 50, 2014, Pages 34938-34952

  Diepenhorst, Natalie A ^a   Petrie, Emma J ^a   Chen, Catherine Z ^b   Wang, Amy ^b   Hossain, Mohammed Akhter ^a   Bathgate, Ross A D ^a   Gooley, Paul R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CHEMICAL ACTIVATION; LIGANDS; PEPTIDES; SCAFFOLDS (BIOLOGY);

AFFINITY INTERACTIONS; COORDINATED INTERACTION; EXTRACELLULAR DOMAINS; FUNCTIONAL INTEGRITIES; LEUCINE-RICH REPEATS; LOW DENSITY LIPOPROTEINS; PROTEIN COUPLED RECEPTORS; TRANSMEMBRANE DOMAIN;

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

MEMBRANE PROTEIN; PROTEIN SERINE THREONINE KINASE; RELAXIN FAMILY PEPTIDE RECEPTOR 1; UNCLASSIFIED DRUG; PROTEIN BINDING; RECEPTOR; RELAXIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; BIOTINYLATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR DYNAMICS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; SPECTROPHOTOMETRY; THERMOSTABILITY; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; EXTRACELLULAR SPACE; GENETICS; HEK293 CELL LINE; METABOLISM; MOLECULAR GENETICS; MUTATION; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; EXTRACELLULAR SPACE; HEK293 CELLS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, PEPTIDE; RELAXIN;

EID: 84918809729     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.600882     Document Type: Article

References (49)

1. Bathgate, R. A., Halls, M. L., van der Westhuizen, E. T., Callander, G. E., Kocan, M., and Summers, R. J. (2013) Relaxin family peptides and their receptors. Physiol. Rev. 93, 405-480
2. Teerlink, J. R., Cotter, G., Davison, B. A., Felker, G. M., Filippatos, G., Greenberg, B. H., Ponikowski, P., Unemori, E., Voors, A. A., Adams, K. F., Jr., Dorobantu, M. I., Grinfeld, L. R., Jondeau, G., Marmor, A., Masip, J., Pang, P. S., Werdan, K., Teichman, S. L., Trapani, A., Bush, C. A., Saini, R., Schumacher, C., Severin, T. M., and Metra, M. (2013) Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381, 29-39
3. Glinka, A., Dolde, C., Kirsch, N., Huang, Y.-L., Kazanskaya, O., Ingelfinger, D., Boutros, M., Cruciat, C.-M., and Niehrs, C. (2011) LGR4 and LGR5 are R-spondin receptors mediating Wnt/[beta]-catenin and Wnt/PCP signalling. EMBO Rep. 12, 1055-1061
4. Hsu, S. Y., Kudo, M., Chen, T., Nakabayashi, K., Bhalla, A., van der Spek, P. J., van Duin, M., and Hsueh, A. J. (2000) The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signaling mechanism for LGR7. Mol. Endocrinol. 14, 1257-1271
5. Büllesbach, E. E., and Schwabe, C. (2000) The relaxin receptor-binding site geometry suggests a novel gripping mode of interaction. J. Biol. Chem. 275, 35276-35280
6. Büllesbach, E. E., and Schwabe, C. (2005) The trap-like relaxin-binding site of the leucine-rich G-protein-coupled receptor 7. J. Biol. Chem. 280, 14051-14056
7. Sudo, S., Kumagai, J., Nishi, S., Layfield, S., Ferraro, T., Bathgate, R. A., and Hsueh, A. J. (2003) H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2. J. Biol. Chem. 278, 7855-7862
8. Hsu, S. Y., Nakabayashi, K., Nishi, S., Kumagai, J., Kudo, M., Sherwood, O. D., and Hsueh, A. J. (2002) Activation of orphan receptors by the hormone relaxin. Science 295, 671-674
9. Hopkins, E. J., Layfield, S., Ferraro, T., Bathgate, R. A., and Gooley, P. R. (2007) The NMR solution structure of the relaxin (RXFP1) receptor lipoprotein receptor class A module and identification of key residues in the N-terminal region of the module that mediate receptor activation. J. Biol. Chem. 282, 4172-4184
10. Kong, R. C., Petrie, E. J., Mohanty, B., Ling, J., Lee, J. C., Gooley, P. R., and Bathgate, R. A. (2013) The Relaxin Receptor (RXFP1) Utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activation. J. Biol. Chem. 288, 28138-28151
11. Datta, A., and Stone, M. J. (2003) Soluble mimics of a chemokine receptor: chemokine binding by receptor elements juxtaposed on a soluble scaffold. Protein Sci. 12, 2482-2491
12. Diepenhorst, N. A., Gooley, P. R., Stone, M. J., and Bathgate, R. A. (2013) Development of a scaffold displaying exoloops of RXFP1. Ital. J. Anat. Embryol. 118, 1-3
13. Chen, C. Z., Southall, N., Xiao, J., Marugan, J. J., Ferrer, M., Hu, X., Jones, R. E., Feng, S., Agoulnik, I. U., Zheng, W., and Agoulnik, A. I. (2013) Identification of small-molecule agonists of human relaxin family receptor 1 (RXFP1) by using a homogenous cell-based cAMP assay. J. Biomol. Screen 18, 670-677
14. Malakauskas, S. M., and Mayo, S. L. (1998) Design, structure and stability of a hyperthermophilic protein variant. Nat. Struct. Biol. 5, 470-475
15. Halls, M. L., Bond, C. P., Sudo, S., Kumagai, J., Ferraro, T., Layfield, S., Bathgate, R. A., and Summers, R. J. (2005) Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8). J. Pharmacol. Exp. Ther. 313, 677-687
16. Zheng, L., Baumann, U., and Reymond, J. L. (2004) An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucleic Acids Res. 32, e115
17. Marley, J., Lu, M., and Bracken, C. (2001) A method for efficient iostopic labeling of recombinant proteins. J. Biomol. NMR 20, 71-75
18. Sreerama, N., and Woody, R. W. (2000) Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal. Biochem. 287, 252-260
19. Hossain, M. A., Lin, F., Zhang, S., Ferraro, T., Bathgate, R. A., Tregear, G. W., and Wade, J. D. (2006) Regioselective disulfide solid phase synthesis, chemical characterization and in vitro receptor binding activity of equine relaxin. Int. J. Peptide Res. Ther. 12, 211-215
20. Akhter Hossain, M., Bathgate, R. A., Kong, C. K., Shabanpoor, F., Zhang, S., Haugaard-Jönsson, L. M., Rosengren, K. J., Tregear, G. W., and Wade, J. D. (2008) Synthesis, conformation, and activity of human insulin-like peptide 5 (INSL5). ChemBioChem 9, 1816-1822
21. Hopkins, E. J., Bathgate, R. A., and Gooley, P. R. (2005) The human LGR7 low-density lipoprotein class A module requires calcium for structure. Ann. N.Y. Acad. Sci. 1041, 27-34
22. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293
23. Johnson, B. A. (2004) Using NMRView to visualize and analyze the NMR spectra of macromolecules. In Protein NMR Techniques (Downing, A. K., ed) pp. 313-352, Humana Press, Totowa, NJ
24. Bruell, S., Kong, R. C., Petrie, E. J., Hoare, B. L., Wade, J. D., Scott, D. J., Gooley, P. R., and Bathgate, R. (2013) Chimeric RXFP1 and RXFP2 receptors highlight the similar mechanism of activation utilizing their N-terminal low density lipoprotein class A modules. Front. Endocrinol. (Lausanne) 4, 171
25. Shabanpoor, F., Bathgate, R. A., Belgi, A., Chan, L. J., Nair, V. B., Wade, J. D., and Hossain, M. A. (2012) Site-specific conjugation of a lanthanide chelator and its effects on the chemical synthesis and receptor binding affinity of human relaxin-2 hormone. Biochem. Biophys. Res. Commun. 420, 253-256
26. Scott, D. J., Layfield, S., Yan, Y., Sudo, S., Hsueh, A. J., Tregear, G. W., and Bathgate, R. A. (2006) Characterisation of novel splice variants of LGR7 and LGR8 reveals that receptor signalling is mediated by their unique low density lipoprotein class A modules. J. Biol. Chem. 281, 34942-34954
27. Krogh, A., Larsson, B., von Heijne, G., and Sonnhammer, E. L. (2001) Predicting transmembrane protein topology with a hidden markov model: application to complete genomes. J. Mol. Biol. 305, 567-580
28. Hofmann, K., and Stoffel, W. (1993) TMbase: a database of membrane spanning proteins segments. Biol. Chem. Hoppe-Seyler 374, 166
29. Néron, B., Ménager, H., Maufrais, C., Joly, N., Maupetit, J., Letort, S., Carrere, S., Tuffery, P., and Letondal, C. (2009) Mobyle: a new full web bioinformatics framework. Bioinformatics 25, 3005-3011
30. Wheatley, M., Wootten, D., Conner, M. T., Simms, J., Kendrick, R., Logan, R. T., Poyner, D. R., and Barwell, J. (2012) Lifting the lid on GPCRs: the role of extracellular loops. Br. J. Pharmacol. 165, 1688-1703
31. Xiao, J., Huang, Z., Chen, C. Z., Agoulnik, I. U., Southall, N., Hu, X., Jones, R. E., Ferrer, M., Zheng, W., Agoulnik, A. I., and Marugan, J. J. (2013) Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1. Nat. Commun. 4, 1953
32. Koole, C., Wootten, D., Simms, J., Miller, L. J., Christopoulos, A., and Sexton, P. M. (2012) The second extracellular loop of the human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation. J. Biol. Chem. 287, 3642-3658
33. Ott, T. R., Troskie, B. E., Roeske, R. W., Illing, N., Flanagan, C. A., and Millar, R. P. (2002) Two mutations in extracellular loop 2 of the human GnRH receptor convert an antagonist to an agonist. Mol. Endocrinol. 16, 1079-1088
34. Klco, J. M., Wiegand, C. B., Narzinski, K., and Baranski, T. J. (2005) Essential role for the second extracellular loop in C5a receptor activation. Nat. Struct. Mol. Biol. 12, 320-326
35. Wurch, T., Colpaert, F. C., and Pauwels, P. J. (1998) Chimeric receptor analysis of the ketanserin binding site in the human 5-hydroxytryptamine 1D receptor: importance of the second extracellular loop and fifth transmembrane domain in antagonist binding. Mol. Pharmacol. 54, 1088-1096
36. Déméné, H., Granier, S., Muller, D., Guillon, G., Dufour, M.-N., Delsuc, M.-A., Hibert, M., Pascal, R., and Mendre, C. (2003) Active peptidic mimics of the second intracellular loop of the V1A vasopressin receptor are structurally related to the second intracellular rhodopsin loop: a combined 1H NMR and biochemical study. Biochemistry 42, 8204-8213
37. Dogo-Isonagie, C., Lam, S., Gustchina, E., Acharya, P., Yang, Y., Shahzadul-Hussan, S., Clore, G. M., Kwong, P. D., and Bewley, C. A. (2012) Peptides from the second extracellular loop of the C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1. J. Biol. Chem. 287, 15076-15086
38. Walser, R., Kleinschmidt, J. H., Skerra, A., and Zerbe, O. (2012) β-Barrel scaffolds for the grafting of extracellular loops from G-protein-coupled receptors. Biol. Chem. 393, 1341-1355
39. Walser, R., Kleinschmidt, J. H., and Zerbe, O. (2011) A chimeric GPCR model mimicking the ligand binding site of the human Y1 receptor studied by NMR spectroscopy. ChemBioChem 12, 1690-1693
40. Pritz, S., Kraetke, O., Klose, A., Klose, J., Rothemund, S., Fechner, K., Bienert, M., and Beyermann, M. (2008) Synthesis of protein mimics with nonlinear backbone topology by a combined recombinant, enzymatic, and chemical synthesis strategy. Angew. Chem. Int. Ed. Engl. 47, 3642-3645
41. Datta-Mannan, A., and Stone, M. J. (2004) Chemokine-binding specificity of soluble chemokine-receptor analogues: identification of interacting elements by chimera complementation. Biochemistry 43, 14602-14611
42. Scott, D. J., Wilkinson, T. N., Zhang, S., Ferraro, T., and Wade, J. D. (2007) Defining the LGR8 residues involved in binding insulin-like peptide 3. Mol. Endocrinol. 21, 1699-1712
43. Scott, D. J., Tregear, G. W., and Bathgate, R. A. (2009) Modeling the primary hormone-binding site of RXFP1 and RXFP2. Ann. N.Y. Acad. Sci. 1160, 74-77
44. Hartley, B. J., Scott, D. J., Callander, G. E., Wilkinson, T. N., Ganella, D. E., Kong, C. K., Layfield, S., Ferraro, T., Petrie, E. J., and Bathgate, R. A. (2009) Resolving the unconventional mechanisms underlying RXFP1 and RXFP2 receptor function. Ann. N.Y. Acad. Sci. 1160, 67-73
45. Kong, R. C., Bathgate, R. A., Bruell, S., Wade, J. D., Gooley, P. R., and Petrie, E. J. (2014) Mapping key regions of the RXFP2 low-density lipoprotein class-A module that are involved in signal activation. Biochemistry 53, 4537-4548
46. Dagil, R., O'Shea, C., Nykjaer, A., Bonvin, A. M., and Kragelund, B. B. (2013) Gentamicin binds to the megalin receptor as a competitive inhibitor using the common ligand binding motif of complement type repeats: insight from the nmr structure of the 10th complement type repeat domain alone and in complex with gentamicin. J. Biol. Chem. 288, 4424-4435
47. Fisher, C., Beglova, N., and Blacklow, S. C. (2006) Structure of an LDLRRAP complex reveals a general mode for ligand recognition by lipoprotein receptors. Mol. Cell 22, 277-283
48. Yasui, N., Nogi, T., and Takagi, J. (2010) Structural basis for specific recognition of reelin by its receptors. Structure 18, 320-331
49. Feng, S., and Agoulnik, A. (2011) Expression of LDL-A module of relaxin receptor in prostate cancer cells inhibits tumorigenesis. Int. J. Oncol. 39, 1559-1565